| ||
Idenix Pharma skids after hepatitis drug delay Businessweek NEW YORK (AP) — Shares of Idenix Pharmaceuticals Inc. tumbled Friday after the Food and Drug Administration delayed human testing of the company's hepatitis C drug IDX20963. THE SPARK: After the markets closed on Thursday, Idenix said the FDA ... See all stories on this topic » | ||
Synta Pharma rises as director buys more shares Yahoo! New Zealand News NEW YORK (AP) -- Shares of Synta Pharmaceuticals Corp. shot up Friday after the company's biggest shareholder disclosed the purchase of more stock. THE SPARK: According to a form filed with the Securities and Exchange Commission Friday, company ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment